|
MTO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.88737914186277E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62525548574877E-12 |
| Normal-vs-Stage2 |
7.08059999521282E-09 |
| Normal-vs-Stage3 |
8.23019996598617E-09 |
| Normal-vs-Stage4 |
3.209300E-04 |
| Stage1-vs-Stage2 |
7.063800E-01 |
| Stage1-vs-Stage3 |
6.907000E-01 |
| Stage1-vs-Stage4 |
6.726400E-01 |
| Stage2-vs-Stage3 |
9.747000E-01 |
| Stage2-vs-Stage4 |
4.529200E-01 |
| Stage3-vs-Stage4 |
4.662200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
1.56089585701125E-11 |
| Normal-vs-Asian |
2.350000E-02 |
| Caucasian-vs-AfricanAmerican |
3.239600E-01 |
| Caucasian-vs-Asian |
6.877800E-01 |
| AfricanAmerican-vs-Asian |
4.530800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
2.51698661912769E-12 |
| Male-vs-Female |
3.511000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.4980018054066E-14 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
7.10329994824122E-09 |
| Normal-vs-Extreme_Obese |
2.371900E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.146800E-01 |
| Normal_Weight-vs-Obese |
4.664300E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.623240E-01 |
| Extreme_Weight-vs-Obese |
3.768000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.203800E-01 |
| Obese-vs-Extreme_Obese |
8.773000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.17579995634532E-09 |
| Normal-vs-Age(41-60Yrs) |
4.65183447317941E-14 |
| Normal-vs-Age(61-80Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(81-100Yrs) |
1.78750347856749E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.790400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.647800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.952440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.249400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.944000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.500000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.99200722162641E-16 |
| Normal-VS-Type2 PRCC |
5.312400519486E-10 |
| Normal-VS-KIRP CIMP |
3.77990000410833E-08 |
| Normal-VS-Unclassified PRCC |
7.57820028951528E-10 |
| Type1 PRCC-VS-Type2 PRCC |
4.145600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.500000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.349800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.514800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.380600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.303600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0073053502424E-12 |
| Normal-vs-N1 |
1.67189999622508E-08 |
| Normal-vs-N2 |
1.2285999995143E-07 |
| N0-vs-N1 |
2.630600E-01 |
| N0-vs-N2 |
1.366390E-01 |
| N1-vs-N2 |
4.158200E-02 |
|
|
